title: Role of 10-Gy boost radiation after breast-conserving surgery for stage I-II breast cancer with a 5-mm negative margin.
abstract: BACKGROUND
  According to the Guidelines for breast-conserving therapy of the Japanese Breast Cancer Society, the surgical margin is "negative" when the minimum distance between the tumor edge and the margin of the resected specimen is more than 5 mm. The value of boost radiation for early breast cancer with a 5-mm negative margin remains unclear.
  
  
  METHODS
  A total of 137 patients with stage I-II breast cancer underwent breast-conserving surgery between July 1987 and August 2002. All of the patients had negative margins according to the Japanese guidelines. Their median age was 50 years and the median follow-up period was 62 months. The entire ipsilateral breast was irradiated to a total dose of 50 Gy (25 fractions). Then an additional 10 Gy (5 fractions) was given to 79 patients, using 6- to 12-MeV electrons (boost group), while 58 patients (no-boost group) received no further radiation. Factors influencing local recurrence were evaluated by univariate and multivariate analyses.
  
  
  RESULTS
  For the entire population, the 5-year overall survival, cause-specific survival, disease-free survival, and local recurrence rates were 96.0%, 96.8%, 94.2%, and 1.67%, respectively. Boost radiation reduced local recurrence, but the improvement was not significant (P = 0.070). Univariate and multivariate analyses failed to detect any factors that were significantly associated with local control. There were no severe complications in either group and there were no differences between the groups in the cosmetic outcome.
  
  
  CONCLUSIONS
  Boost radiation can be performed for stage I-II breast cancer with negative margins (Japanese guidelines), and showed a tendency to decrease local recurrence. A large randomized controlled study is necessary to establish final conclusions.
authors: Department of Radiology, Faculty of Medicine, Shimane University, Enya-cho 89-1, Izumo, Shimane, 693-8501, Japan. notani@med.shimane-u.ac.jp
authors: Masafumi
authors: M
authors: Notani
authors: Nobue
authors: N
authors: Uchida
authors: Hajime
authors: H
authors: Kitagaki
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D015331:Cohort Studies; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental / Q000379:methods; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate
references: Cancer. 2003 Feb 15;97(4):926-33
references: 12569592
references: Eur J Cancer. 1995 Sep;31A(10):1574-9
references: 7488404
references: Radiother Oncol. 2004 Jul;72(1):25-33
references: 15236871
references: Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1281-8
references: 16924719
references: J Clin Oncol. 1999 Aug;17(8):2326-33
references: 10561294
references: Eur J Cancer. 2001 Oct;37(15):1820-7
references: 11576834
references: Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):168-75
references: 16198507
references: N Engl J Med. 1995 Nov 30;333(22):1456-61
references: 7477145
references: Cancer. 2003 Feb 15;97(4):910-9
references: 12569590
references: Lancet. 1996 Sep 14;348(9029):708-13
references: 8806289
references: Breast Cancer. 2003;10(2):129-33
references: 12736565
references: CMAJ. 1998 Feb 10;158 Suppl 3:S35-42
references: 9484277
references: Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):833-42
references: 2170305
references: Breast Cancer. 2005;12(2):91-8
references: 15858438
references: Lancet. 2000 May 20;355(9217):1757-70
references: 10832826
references: J Clin Oncol. 1997 Mar;15(3):963-8
references: 9060534
references: N Engl J Med. 2001 Nov 8;345(19):1378-87
references: 11794170
references: Cancer J Sci Am. 1998 Sep-Oct;4(5):302-7
references: 9815294
references: Cancer. 1985 Sep 1;56(5):979-90
references: 2990668